Morningstar Investment Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,641
Closed -$554K 171
2024
Q3
$554K Buy
6,641
+1,054
+19% +$83.1K 0.01% 264
2024
Q2
$430K Buy
5,587
+1,636
+41% +$120K ﹤0.01% 266
2024
Q1
$271K Sell
3,951
-1,906
-33% -$123K ﹤0.01% 299
2023
Q4
$330K Buy
+5,857
New +$313K ﹤0.01% 337

Other funds holding BSX

Morningstar Investment Services's BSX Position: Q4 2024 in Review

Morningstar Investment Services sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 6,641 shares — an estimated $554K sold.

Morningstar Investment Services first reported a position in BSX in Q4 2023 and held it in 4 quarters. The position peaked at $554K in Q3 2024. 1,516 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Morningstar Investment Services reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
  • Morningstar Investment Services sold 6,641 Boston Scientific shares in Q4 2024, an estimated $554K.
  • Morningstar Investment Services first reported a position in Boston Scientific in Q4 2023 and held it in 4 quarters.
  • Morningstar Investment Services's Boston Scientific position peaked at $554K in Q3 2024.
  • 1,516 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Morningstar Investment Services's 13F filing for Q4 2024, filed 12 Feb 2025.